Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same

Details for Australian Patent Application No. 2008321429 (hide)

Owner Boehringer Ingelheim International GmbH Evec Inc.

Inventors Takada, Kenzo; Nakajima, Kantou; Park, John; Kistler, Barbara

Agent Davies Collison Cave

Pub. Number AU-A-2008321429

PCT Pub. Number WO2009/064399

Priority 2007-294945 13.11.07 JP; PCT/ JP2008/052471 14.02.08 JP

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/064399 Priority application(s): WO2009/064399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321432-Combination EAS and RFID label or tag using a hybrid RFID antenna

2008321418-New extracts of deschampsia antarctica desv. with antineoplastic activity